<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04552522</url>
  </required_header>
  <id_info>
    <org_study_id>090/2563</org_study_id>
    <nct_id>NCT04552522</nct_id>
  </id_info>
  <brief_title>Immunological Response After Shrimp Oral Immunotherapy Treatment</brief_title>
  <official_title>Immunological Response After Shrimp Oral Immunotherapy Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Oral immunotherapy is effective in desensitized food allergy. Shrimp allergy is increasing in&#xD;
      Thailand. So the purpose of our study is to determine level of specific immunoglobulin E&#xD;
      antibodies to shrimp, Immunoglobulin G4 and immunoblot analysis in shrimp allergy patients&#xD;
      after shrimp oral immunotherapy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All subject in this study were sensitized to shrimp. All patient was clinically evaluated,&#xD;
      with focus on shrimp allergy by medical history, medical examination and gold standard oral&#xD;
      food challenge test. Compare oral immunotherapy to shrimp and shrimp avoidance. Blood sample&#xD;
      was taken for baseline determination of immunoglobulin E antibodies to shrimp. The primary&#xD;
      outcome was the specific immunoglobulin E antibodies to shrimp,Immunoglobulin G4 and&#xD;
      immunoblot analysis in case that oral immunotherapy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 28, 2020</start_date>
  <completion_date type="Anticipated">July 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>specific Immunoglobulin E, Immunoglobulin G4, immunoblot analysis from Desensitized to shrimp allergen</measure>
    <time_frame>1 year</time_frame>
    <description>To follow-up the level of specific Immunoglobulin E, Immunoglobulin G4, immunoblot analysis from Desensitized to shrimp allergen</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse event from Shrimp oral immunotherapy</measure>
    <time_frame>1 year</time_frame>
    <description>To follow up adverse event from Shrimp oral immunotherapy</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Allergy to Shrimp</condition>
  <condition>Immunotherapy</condition>
  <arm_group>
    <arm_group_label>Shrimp allergy with Intend to eat shrimp</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Case shrimp Immunoglobulin E mediated allergy and intend to eat shrimp and start oral immunotherapy for shrimp</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Shrimp allergy with avoid shrimp</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Case shrimp allergy with avoid shrimp</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>shrimp allergy with intend to eat shrimp</intervention_name>
    <description>shrimp allergy with intend to eat shrimp and treat with oral immunotherapy</description>
    <arm_group_label>Shrimp allergy with Intend to eat shrimp</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 12 - 40 years old&#xD;
&#xD;
          -  History of Immunoglobulin E-mediated shrimp allergy &gt; 3 episode/year or disturb&#xD;
             quality of life&#xD;
&#xD;
          -  Positive oral food challenge test for shrimp&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of shrimp anaphylaxis (include cardiovascular or neurological symptoms)&#xD;
&#xD;
          -  Shellfish dependent exercise induced anaphylaxis&#xD;
&#xD;
          -  History of cardiovascular disease, uncontrolled asthma, severe atopic dermatitis&#xD;
&#xD;
          -  History of Beta-blocker, Angiotensin-converting enzyme inhibitor, Angiotensin receptor&#xD;
             blocker, Calcium channel blocker&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Punchama Pacharn, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mahidol University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Punchama Pacharn, MD</last_name>
    <phone>024197000</phone>
    <phone_ext>5670</phone_ext>
    <email>punchama@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Siriraj Hospital</name>
      <address>
        <city>Bangkoknoi</city>
        <state>Bangkok</state>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Punchama Pacharn, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <reference>
    <citation>Pajno GB, Fernandez-Rivas M, Arasi S, Roberts G, Akdis CA, Alvaro-Lozano M, Beyer K, Bindslev-Jensen C, Burks W, Ebisawa M, Eigenmann P, Knol E, Nadeau KC, Poulsen LK, van Ree R, Santos AF, du Toit G, Dhami S, Nurmatov U, Boloh Y, Makela M, O'Mahony L, Papadopoulos N, Sackesen C, Agache I, Angier E, Halken S, Jutel M, Lau S, Pfaar O, Ryan D, Sturm G, Varga EM, van Wijk RG, Sheikh A, Muraro A; EAACI Allergen Immunotherapy Guidelines Group. EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy. Allergy. 2018 Apr;73(4):799-815. doi: 10.1111/all.13319. Epub 2017 Dec 5.</citation>
    <PMID>29205393</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>September 13, 2020</study_first_submitted>
  <study_first_submitted_qc>September 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 17, 2020</study_first_posted>
  <last_update_submitted>July 23, 2021</last_update_submitted>
  <last_update_submitted_qc>July 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Shrimp allergy</keyword>
  <keyword>Oral immunotherapy</keyword>
  <keyword>Specific Immunoglobulin E</keyword>
  <keyword>Skin sensitization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

